Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Akebia Therapeutics Inc. logo

Akebia Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.10
 
USD
  
-0.03
  
(-2.65%)
Optionable: Yes  Market Cap: 237 M  90-day average vol: 5,159,133

Previous close: 1.13  Open: 1.11  Bid: 1.1  Ask: 1.11
52 week range    
0.78   
   2.48
Peers   
AMGN / 
NVS / 
JNJ / 
NKTR / 
Last updated: Thursday 23rd May 2024
37
MarketXLS Rank
40
Value
23
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AKBA Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock87 M
Amortization of intangibles-2 M55 M55 M36 M59 M59 M
Basic EPS from continuing operations-2.36-2.77-1.7-0.51-0.28
Basic EPS total0.33-2.36-2.77-1.7-0.51-0.28
Basic weighted shares outstanding15 M26 M38 M44 M58 M118 M138 M166 M183 M187 M
Cost of sales-6 M145 M296 M153 M86 M74 M
Depreciation-49000.0-96000.0-295000.0-600000.0-900000.02 M2 M2 M2 M
DepreciationAndAmortization-49000.0-96000.0-295000.0-600000.0-900000.02 M2 M2 M2 M
Diluted EPS total-8.04-2.29-3.6-1.69-2.47-2.36-2.77-1.7-0.51-0.28
Diluted normalized net income/share-1.7-0.51-0.28
Diluted weighted shares outstanding5 M27 M38 M50 M58 M118 M138 M166 M183 M187 M
ExciseTaxes36 M
GainOnSaleOfPPE-524000.0
GainOnSaleOfSecurity1 M800000.0
GeneralAndAdministrativeExpense15 M18 M22 M-3 M-4 M149 M154 M174 M175 M100 M
Gross operating profit700233.02 M181 M200 M190 M-601000.060 M207 M120 M
Income before tax-37 M-61 M-136 M-74 M-172 M-286 M-383 M-283 M-94 M-52 M
Income restructuring and M&A-118852.016 M181000.0
Income taxes-28 M-7 M
Interest income237000.0510000.0901000.03 M6 M792000.0-9 M-20 M-16 M-6 M
LossAndLossAdjustmentExpectedIncurred32 M36 M
MiscOtherSpecialCharges700000.0287000.0-188000.0204000.081000.0-794000.02 M2 M2 M887000.0
Net income from total operations-37 M-61 M-136 M-74 M-144 M-280 M-383 M-283 M-94 M-52 M
NetIncomeCommonStockholders-124 M-61 M-136 M-74 M-144 M-273 M-261 M-276 M-94 M-52 M
NetIncomeContinuousOperations-37 M-61 M-136 M-74 M-144 M-280 M-383 M-283 M-94 M-52 M
NetNonOperatingInterestIncomeExpense237000.0510000.0901000.03 M6 M792000.0-9 M-20 M-16 M-6 M
NetOperatingInterestIncomeExpense206000.0510000.0
Normalized income-40 M
Operating income-38 M-62 M-136 M-77 M-178 M-286 M-376 M-265 M-81 M-46 M
Operating income before depreciation (EBITDA)-37 M-60 M-135 M-72 M-171 M-248 M-350 M-245 M-54 M-17 M
OperatingExpense-38 M-62 M-138 M-258 M-378 M476 M376 M326 M288 M167 M
Other income net-700000.0-287000.0188000.0-204000.0-81000.0794000.030 M-2 M-2 M-363000.0
Other special charges36 M
OtherGandA15 M18 M22 M-3 M-4 M149 M154 M174 M175 M100 M
OtherImpairmentOfCapitalAssets32 M
OtherOperatingExpenses-38 M-62 M-138 M-258 M67000.0-4 M-3 M-3 M-3 M-3 M
OtherTaxes36 M
OtherWriteOff400000.0100000.0
OtherunderPreferredStockDividend87 M
PreferredStockDividends87 M
RentAndLandingFees15 M18 M22 M-3 M-4 M
Research & development expense23 M43 M116 M231 M291 M323 M218 M148 M130 M63 M
ResearchExpense23 M43 M116 M231 M291 M323 M218 M148 M130 M63 M
RestructringAndMnAIncome-118852.016 M181000.0
Revenue per share-2 M55 M55 M36 M59 M59 M
SalariesAndWages-6 M-5 M-6 M-12 M-19 M
Selling Gen & administrative expense15 M18 M22 M27 M87 M149 M154 M174 M175 M100 M
SellingAndMarketingExpense27 M87 M
SellingExpense27 M87 M
Special income/charges118852.0-36 M-16 M-181000.0
Total Income available for interest expense (EBIT)-37 M-61 M-136 M-74 M-172 M-286 M-383 M-283 M-94 M-52 M
Total common shares outstanding20 M38 M39 M48 M117 M130 M154 M181 M184 M209 M
Total net income-37 M-61 M-136 M-74 M-144 M-280 M-383 M-283 M-94 M-52 M
Total ordinary shares210 M210 M210 M210 M210 M210 M210 M210 M210 M210 M
Total revenues700233.02 M181 M208 M335 M295 M214 M292 M195 M
TotalExpenses-38 M-62 M-138 M-258 M-384 M621 M672 M479 M373 M241 M
TotalRevenue700233.02 M181 M208 M335 M295 M214 M292 M195 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University